Info from Our Doctors

Information From Our Doctors


Tulane Cancer Center

On behalf of the faculty, staff and patients of the Tulane Cancer Center, I salute Cancer Crusaders for your remarkable record of support for cancer research in the New Orleans area.  Not only have you championed the importance of research in finding a cure for cancer, but your membership has actively and tirelessly generated important funds to support our research efforts.  Your motivation and your drive are enviable, and your partnership with us invaluable.

Tulane Cancer Center continues to invest your hard-earned dollars in the support of our cancer investigators and their ongoing research efforts.

Cancer Crusaders Next Generation Sequence Analysis Core Facility
Our Cancer Crusaders Next Generation Sequence Analysis Core facility has continued to develop and expand as a result of your philanthropy.  This important resource provides our cancer investigators state-of-the-art technology for thorough analysis of nearly all of the genetics related to a biological sample in one test.  Our investigators must use this technology in order to remain competitive when applying for federal and other research funding, and many of them previously contracted for NGS services with other institutions.  Now, because of your hard work, they have the luxury of in-house NGS.  And while there are many NGS centers located throughout the world, the Cancer Crusaders NGS Core is unique in that it not only generates voluminous amounts of invaluable data, but it also helps our researchers to develop the expertise to analyze and interpret the data themselves.  In short, the facility helps to position us comparably to many other larger institutions—thanks to your generosity.

Transformative Experiment Fund (TEF)
I have also been working over the past few months with my executive leadership to fine-tune a new pilot program – the Transformative Experiment Fund (TEF) – that we believe will help our cancer investigators obtain new long-term, programmatic research funding, thanks in large part to Cancer Crusaders support.  The principle of the initiative is to fund very specific experiments needed to provide preliminary data for preparing highly competitive and hopefully successful grant applications.  Applicants for TEF support must provide a clear rationale of the funding needed and the reason why the transformative experiment is critical for successful grant funding in the near future. Our goal is to support vital experiments that would be difficult for investigators to perform in their current funding situation but at the same time are potentially pivotal to future funding success.  If the program succeeds as planned, in coming months I will be able to report on grants that have been awarded to Tulane Cancer Center faculty members who were supported by the Cancer Crusaders via the TEF.
On behalf of my research faculty who will be assisted through this new initiative as well as the NGS Core and cancer patients who may benefit through the increased momentum of their research discovery, I thank you again for your invaluable support.  We are grateful every day for the faith you have placed in us, and we will work hard to continue the progress you have made possible.

Prescott Deininger, Ph.D.
Director, Tulane Cancer Center
Joe W. and Dorothy Dorsett Brown Foundation Chair in Oncology
Professor of Epidemiology



LSU Health Sciences Center Stanley S. Scott Cancer Center 

Since 1976 the Cancer Crusaders have contributed in many ways to the mission of the LSUHSC Cancer Center by championing numerous initiatives in order to gather community support, increase awareness about cancer clinical trials, and provide information on cancer screening and cancer treatment options. In order to ensure and maintain recruitment of nationally and internationally recognized scientific investigators who can build cancer clinical and research programs in Louisiana, the Cancer Crusaders and the LSUHSC Cancer Center have made a strategic decision to invest in creating endowed chairs and professorships. To date, we have been able to create a Cancer Crusaders Endowed Chair and an Endowed Professorship that have helped our Center recruit nationally recognized research teams and retain renowned clinicians for the express purpose of benefitting individuals with cancer in our state.

Through the LSUHSC Cancer Center and Cancer Crusaders collaboration, we created the Al Copeland-Cancer Crusaders Chair in Neuroendocrine Cancer. This chair allowed the LSUHSC Cancer Center to build a new research program to study viruses which cause a large number of cancers, including cervical, head and neck, lymphomas and rare tumors such as Merkel cell carcinoma. The creation of this new program has allowed us to recruit successful, dynamic researchers and the program has distinguished itself by being named the only AIDS Malignancy Consortium site in the region. Furthermore, it has led to the successful opening of multiple new NIH and pharmaceutical clinical trials and sets the stage for developing additional new programs that have the potential to change the dynamics in the fight against cancer.

As the Co-Director of the Louisiana Cancer Research Center (LCRC) and Director of the LSU Health New Orleans Stanley S. Scott Cancer Center, I am one of 28 scientific experts, cancer leaders and patient advocates who will help guide the scientific direction of Vice President Joe Biden’s National Cancer Moonshot Initiative. I am also honored to hold the Al Copeland/Cancer Crusaders Chair in Neuroendocrine Cancer, and I am the only member of the National Cancer Institute’s Blue Ribbon Panel from Louisiana. The funding from the Cancer Crusaders will allow us to address the National Cancer Institute’s Blue Ribbon Panel (Vice President Biden’s Cancer Moonshot Program) national initiative in immunotherapy and combination therapies. The Cancer Center looks forward to another successful year of collaboration with the Cancer Crusaders.

Augusto Ochoa, M.D.
Director, LSUHSC Stanley S. Scott Cancer Center
Al Copeland/ Cancer Crusaders Chair
Professor of Pediatrics
Co-Director LCRC

image description
image description